Arkolith/Insider Trading/RAPP/Form 4

Yeleswaram Krishnaswamy

Chief Development OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Jan 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$85K
Net Open-Market Flow
-$85K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2025Grant(A)9K——300K
Dec 31, 2025Sell(S)3K$30.05$85K297K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-002469) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML